Tron A Moger
Overview
Explore the profile of Tron A Moger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
497
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Brathovde M, Moger T, Aalen O, Grotmol T, Veierod M, Valberg M
Stat Med
. 2023 Aug;
42(23):4207-4235.
PMID: 37527835
Additive frailty models are used to model correlated survival data. However, the complexity of the models increases with cluster size to the extent that practical usage becomes increasingly challenging. We...
2.
Kvamme M, Lie E, Uhlig T, Moger T, Kvien T, Kristiansen I
Rheumatology (Oxford)
. 2019 Dec;
59(4):917.
PMID: 31865376
No abstract available.
3.
Hofvind S, Holen A, Aase H, Houssami N, Sebuodegard S, Moger T, et al.
Lancet Oncol
. 2019 May;
20(6):795-805.
PMID: 31078459
Background: Digital breast tomosynthesis is an advancement of mammography, and has the potential to overcome limitations of standard digital mammography. This study aimed to compare first-generation digital breast tomo-synthesis including...
4.
Valberg M, Grotmol T, Tretli S, Veierod M, Moger T, Devesa S, et al.
Eur J Epidemiol
. 2016 Jul;
32(6):511-520.
PMID: 27431530
After the introduction of the prostate specific antigen (PSA) test in the 1980s, a sharp increase in the incidence rate of prostate cancer was seen in the United States. The...
5.
Damlien L, Davidsen N, Nilsen M, Godo A, Moger T, Viktil K
Eur J Emerg Med
. 2015 Dec;
24(5):333-339.
PMID: 26657211
Objective: This study aimed to develop an innovative prioritizing model for conducting medication reconciliation (MR) at a fast-paced workflow emergency department (ED) and to implement an efficient working model for...
6.
Moger T, Bjornelv G, Aas E
Eur J Health Econ
. 2015 Aug;
17(6):745-54.
PMID: 26239280
Background: The shift towards earlier stages of disease advancement at diagnosis when introducing mammography screening is expected to affect the treatment costs of breast cancer. Materials And Methods: We collected...
7.
Kvamme M, Lie E, Uhlig T, Moger T, Kvien T, Kristiansen I
Rheumatology (Oxford)
. 2015 Jan;
54(7):1226-35.
PMID: 25573840
Objective: The objective of this study was to estimate the additional costs and health benefits of adding a TNF inhibitor (TNFi) (adalimumab, certolizumab, etanercept, golimumab, infliximab) to a synthetic DMARD...
8.
Blix H, Viktil K, Moger T, Reikvam A
Pharm Pract (Granada)
. 2014 Aug;
8(1):50-5.
PMID: 25152793
Unlabelled: Drugs with narrow therapeutic index (NTI-drugs) are drugs with small differences between therapeutic and toxic doses. The pattern of drug-related problems (DRPs) associated with these drugs has not been...
9.
Valberg M, Grotmol T, Tretli S, Veierod M, Moger T, Aalen O
Am J Epidemiol
. 2013 Nov;
179(4):499-506.
PMID: 24219863
Using a 2-level hierarchical frailty model, we analyzed population-wide data on testicular germ-cell tumor (TGCT) status in 1,135,320 two-generational Norwegian families to examine the risk of TGCT in family members...
10.
Svensson E, Rogvin M, Hultman C, Reichborn-Kjennerud T, Sandin S, Moger T
Schizophr Res
. 2013 Apr;
147(1):140-146.
PMID: 23541033
Background: Using a frailty model approach, we aim to evaluate the effect of early-life risk factors on susceptibility and age at diagnosis of schizophrenia. We assume paternal age and familial...